ABSTRI\m. Newborn infants have an increased morbidity and mortality from infection caused in part by diminished polymorphonuclear leukocyte (PAIN) function and impaired recruitment of P h l N to sites of inflammation. Recent studies in our laboratory and others have demonstrated the in vitro expression of several cytokines, including IL-1-8, in adult human peripheral blood PAIN. Because newborn infants have an impaired inflammatory response, we sought to compare the synthetic capability and regulation of cytokine espression in neonatal and adult PAIN. In our present studies, we found that tumor necrosis factor-a and lipopolysaccharide could induce IL-1-8 espression in both neonatal and adult P h I N and that neonatal I'hlN produced significantly more IL-1-8 when compared with adult PAIN. The I'hlN chemotactic peptide DIet-Leu-Phe did not induce IL-1-8 espression in either adult or neonatal PRIN. Elevated cytokine expression by neonatal I'hIN may play an important role in the regulation of the immune and inflammatory systems at sites of injury and infection in neonates. (Perliarr Res 34: 249-252, 1993) Abbreviations PhIN, polymorphonuclear leukocyte LPS, lipopolysaccharide TNF, tumor necrosis factor TNF-(r, tumor necrosis factor-a GhI-CSF, granulocyte monocyte colony stimulating factor fhlLP, N-formyl-methionyl-leucyl-phenylalanine Proinflammatory cytokines such as IL-1-8, TNF, IL-6, and IL-8 have been demonstrated in cells and tissue in several inflammatory diseases. The local expression of these cytokines is thought to be critical in the recruitment and activation of inflammatory cells. For example, IL-I-@ and T N F have been shown to induce the recruitment of PMN it1 vivo (1, 2). It1 vitro pretreatment of PMN with IL-1-0, TNF, or GM-CSF has been shown to prime oxidative metabolism and phagocytosis in these cells (3) (4) (5) (6) . IL-1-0 and T N F also appear to stimulate release of other mediators of inflammation including thromboxane, 6-ketoprostaglandin F,,, and prostaglandin E2 (7).
Previously, a wide variety of cell types such as monocytes, endothelial cells, and fibroblasts have been shown to produce IL-I-@ in response to various factors, such as endotoxins and cytokines. Historically, PMN were not considered a potential source of cytokines because they were thought to be terminally differentiated without protein synthetic capability. Interestingly, 1 recent studics in our laboratory and others have shown that PMN are able to synthesize proteins when givcn the appropriate stimulus (6-1 1). For rxamplc, we have demonstrated that adult human peripheral blood PMN can produce IL-I-/3 in response to 1L-l -a, IL-1-0, and TNF-(U ( 10, 1 1 ). Our studics also demonstrated that IL-1-@ or T N F induced PMN to transiently express IL-1-8 mRNA, with peak expression at 1 h, and return to untreated levels by 2 h. In other studies, adult PMN have been shown to produce IL-1-0 in response to TNF, LPS, or GM-CSF (12, 13). T o our knowledge, nothing is known about the ability of neonatal PMN to produce cytokines.
Impaired neonatal host defense is thought to be at least partially responsible for increased neonatal morbidity and mortality from infection (14-16). Inasmuch as IL-I-@, TNF, LPS, and GM-CSF have been shown to be important priming or activating agents of PMN, we investigated their effect on IL-I-@, TNF, and GM-CSF. expression in neonatal and adult PMN. Anticipating decreased PMN cytokine expression by neonatal PMN, we were surprised to find that TNF-(U and LPS could induce IL-1-13 expression in both neonatal and adult PMN and that neonatal PMN consistently produced more amounts of 1L-I-@ than adult PMN. The recognition of cytokines as important regulators of immune and inflammatory reactions suggests that elevated IL-1-8 expression by neonatal PMN may be significant for immune and inflammatory regulation in the neonate.
h1ATERIALS A N D METHODS
.~ldirl~ ~t l d t~c~onu~ul I1,\fiV. Placentas were obtained from healthy women who underwent repeat cesarean sections under regional anesthesia, with no complications of pregnancy, labor, or delivery and whose newborns were in good health. Blood was obtained from the fetal side of placentas (neonatal cord blood) within 5 min of birth. Blood was also obtained from healthy adult volunteers. All blood samples were immediately mixed with preservative-free sodium heparin (50 pL/mL blood) and brought to the laboratory for analysis. Informed consent to sample blood was obtained from all parents or adult subjects in accordance with the University of Connecticut and Hartford Hospital Institutional Review guidelines.
ElfN p~rrificu~ioti. Human and neonatal PMN were isolated from blood using Ficoll-Hypaque density centrifugation followed by 3% dextran (Pharmachem, Bethlehem, PA) sedimentation (17). Residual red blood cells were hypotonically lysed, and the PMN were washed three times with 50 m L of 0.05 M PBS, pH 7.4. The resulting cells were 95 to 98% PMN as determined by morphology of Wright's stained cells and more than 99% viable as determined by trypan blue exclusion. For these studies, all cells were prepared and maintained using sterile reagents and techniques. All reagents used for these studies were either pharmaceutical grade or contained ~0 . 1 endotoxin units/mL of endotoxin as determined by the amebocyte lysate assay (Whittaker, Walkersville, MD). PMN culture conditions. For all studies, PMN were cultured analyzed for 1L-I-P, TNF, and GM-CSFantigcn by commercially at 37°C with 5% C 0 2 in minimum essential medium (GIBCO, available ELISAs (Cistron Biotechnology, Pine Brook, NJ). Grand Island, NY) containing 10% FCS (HyClone Inc., UT). T o Statistical atla/~~sis. All data for these studies are expressed as initiate our studies, we evaluated the ability of T N F (500 U/mL; mean + SEM and analyzed using paired t test. Statistics were mL) were incubated in polypropylene microcentrifuge tubes in CAI. A p value of c0.05 was considered significant. minimal essential medium containing 10% low endotoxin fetal serum with and without T N F (500 U/mL; 1.5 X lo-' M). After RESULTS incubation for various periods (1, 2, 3, and 4 h) at 37°C in a humidified 5% COz atmosphere, PMN and supernatants were TNF irldlrctior~ dcjvtokirle c>.tprc~ssion. Based on our previous harvested by centrifugation at 500 x for 10 min at 4 "~. ~h~ studies of IL-I-P antigen expression in adult PMN, we initiated resulting pellet was lysed by the addition of 200 pL of lysing experimentson the effect of T N F (500 U/mL; 1.5 lo-' M) on solution (0.1% ~r i t~~ X-100 plus 10% fetal serum in minimum IL-I-P antigen expression in neonatal and adult PMN. Because essential medium). The cell lysates and supernatants were evalOur previous studies indicated that T N F induced IL-1-0 expresuated for IL-I-P antigen by a commercially available ELIS* sion, which generally peaked in less than 4 h poststimulation, we (Cistron Biotechnology, Pine Brook, NJ).
TNF UNITSIML
evaluated IL-1-P expression in adult and neonatal PMN at 1 to Once we established the optimum incubation period for cyto-4 h poststimulation. Our initial studies indicated that T N F kine expression (3 h), we evaluated the ability of various concen-induced significant cell associated IL-1-P antigen expression in both neonatal and adult PMN compared with corresponding trations of T N F (0, 20, 100, and 500 U/mL) to induce IL-I-P control (nonstimulated) PMN. Peak expression was seen at in both and adult PMN at h. For these post-TNF exposure (i,c, 57 + 6 pg/106 adult PMN rcrslrs 76 + studies, purified PMN were treated using the same experimental pg,lOh neonatal PMN). Throughout the I-to 4-h incubation conditions as described above but were stimulated with various time, control (nonstimulated) PMN produced only negligible concentrations of TNF ( '9 20, 'O0? and 500 UImL; O M, amounts of IL-1-P (0.2 + 0.1 to 0.3 + 0.2 pg/lOh adult PMN lo-" M, 3 x lo-'' M, 1.5 x lo-' M ) for 3 h. The PMN l~s a t e s yc7rJ,,s 0.01 + 0.001 to 2 + 0.8 pg/lOh neonatal PMN). In and resulting supernatants were again harvested by centrifugation addition, neither adult or neonatal culture supernatants of these at 500 x g for 10 min at 4°C. The resulting pellet was lysed with cells had detectable IL-I-P antigen after any incubation time (1 0.1 % triton (see above) and, with the corresponding supernatant, to 4 h), with or without TNF was evaluated for IL-I-P antigen by ELISA. We next determined the influence of various T N F concentraWe also investigated whether other stimuli (IL-I-@, LPS, and tions on IL-I-P expression by neonatal and adult p M N at the fh4LP) could induce IL-I-P, TNF, and GM-CSF expression in single 3-h time point. As shown in Figure 1 , T N F induced a either neonatal or adult PMN. Purified PMN (1 x 1O7/mL) were dose-dependent increase in cell associated IL-1-0 antigen exprestreated under the same experimental conditions as described sion in both neonatal and adult pMN. These studies also demabove but were stimulated with or without IL-I-P (1 ng/mL; 5.9 onstrated that neonatal PMN produced significantly higher levels x lo-" M), LPS (10 pg/mL), and fh4LP (I x lo-' M) for 3 and of IL-I-@ compared with TNF-stimulated adult PMN. Again, no 24 h. After each incubation period, the PMN and supernatants detectable IL-I-@ antigen was seen in the PMN supernatants of were harvested as described above. The resulting neonatal and neonatal or adult PMN at 3 h incubation with any TNFconcenadult cell lysates and their corresponding supernatants were trations tested. These studies clearly demonstrate that neonatal Fig. 2 . PMN IL-1-13 expression in neonates and adults in response to TNF, LPS, and fMLP. PMN from neonates (slripcd bars) and adults (solid bars) were incubated in TNF, LPS, and fMLP for 3 h (lop) and 24 h (hotrotn). The amount of IL-1-13 antigen present in cell lysates after TNF stimulation at 3 and 24 h was significantly different from control in both neonates ( p < 0.001 and p < 0.02, respectively) and adults ( p < 0.001 and p < 0.07, respectively). The amount of IL-1-13 produced after LPS stimulation at 3 and 24 h was also significantly different from control in both neonates ( p < 0.002 and p < 0.0001, respectively) and adults ( p < 0.005 and p < 0.01, respectively). There were no significant direrences between control and fMLP values for either neonates or adults. PMN can be stimulated by a cytokine (in this case, TNF) to express IL-I-/3 antigen and that neonatal PMN produce statistically more levels of the IL-I-P cell-associated antigen when stimulated with TNF.
TNF, LPS, andf;l.ILP indtiction ofcytokine expression. Additional studies were undertaken to determine whether other cell activators such as LPS or fMLP could induce IL-I-@ expression in neonatal or adult PMN. Short (3 h) and long (24 h) stimulation times using TNF, LPS, and fMLP were evaluated (Fig. 2) . TNF and LPS stimulated IL-I-@ expression in both neonatal and adult PMN after 3-and 24-h incubation times. Neonatal levels of 1L-I-j3 antigen were significantly higher than those of adults. Interestingly, fMLP, a potent stimulator of PMN activation, had no effect on IL-I -P expression of cell-associated IL-I -P antigen after 3 or 24 h incubation. IL-I-@ was undetectable in supernatants after a 3-h incubation but was present in the 24-h PMN supernatants (TNF: adult 7 f 2 pg/mL, neonate 9 f 3 pg/mL; LPS: adult 2 1 f 9 pg/mL, neonate 13 + 4 pg/mL). LPS most effectively induced IL-I-P antigen expression in both neonatal and adult PMN of all the stimuli tested. Last, we analyzed the same PMN lysates and supernatants stimulated with TNF, LPS, fMLP, or IL-I-P for GM-CSF and TNF antigen expression. No detectable levels of either cytokine were found after 3-or 24-h incubations (data not shown).
DISCUSSION
Cytokines, such as IL-I-P and TNF, have been demonstrated in the tissues of patients with a number of inflammatory diseases, and their local expression is generally thought to be critical in the regulation of tissue cells and the recruitment of cells to sites of tissue injury ( 1 8). Monocytes/macrophages have been noted to be primary sources of cytokine expression, consistent with their role as important immunoregulatory cells. In contrast, PMN have traditionally been considered effector cells with little immunoregulatory function. The discovery that PMN had the capacity to produce cytokines has altered this concept (10-13). The results of our present study clearly demonstrate that neonatal PMN can express at least one major cytokine (IL-I-@) when
